Brief: Korea United Pharm signs contract worth 74.34 bln won
Nov 15 (Reuters) - Korea United Pharm Inc 033270.KS :
* Says it signs contract with Beijing Meone Pharma.
Technology(Meone) to provide incrementally modified drug in
China, on Nov. 15
* Contract amount is 74.34 billion won
Source text in Korean: https://goo.gl/yiU5lE
Further company coverage: 033270.KS
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: hedy.cui.reuters.com@reuters.net))
Recent news on Korea United Pharm
See all newsBrief: Korea United Pharm To Divest 9.4 Billion Won Worth Of Own Shares
Brief: Korea United Pharm To Divest 19 Billion Won Worth Of Own Shares
Brief: Korea United Pharm Q3 Operating Profit 12.5 Billion Won, Down 17% From Year Earlier
Brief: Korea United Pharm Q2 Operating Profit 10.8 Billion Won, Down 14% From Year Earlier
Brief: Korea United Pharm Q1 Operating Profit 13.8 Billion Won, Down 18.3% From Year Earlier